Real World Data in Pricing Models, Specialty Drug Pricing Among Issues to be Addressed
(Chicago) – Pricing and market access professionals will have the opportunity to address a variety of subjects and challenges at the 3rd Annual Pharmaceutical Strategic Pricing and Market Access Conference in Philadelphia on October 17-18, 2016. This meeting will offer a chance to share insights on the latest trends, forecasted data, and legislative actions surrounding the pharmaceutical pricing space.
Some of the most successful and influential leaders in the pharmaceutical pricing industry will be on hand to lead sessions, panel discussions, and workshops throughout the two-day event, including Satish Valluri of Pfizer, Rick Chapman of ICER, and Gary Binder of Celgene. Conference delegates will have the exclusive opportunity to participate in open-floor discussion formats, as well as peer-to-peer networking during breakout sessions and small group workshops.
Topics to be discussed cover a range of current issues and forecasting insight, including value-based contracting collaborations, state-level price transparency, and an analysis of the implications of the 2016 Presidential candidates’ policies. Case studies on specialty drug pricing and integrating real-world data, as well as lectures on state-level price transparency legislation and pricing sustainability will be shared, and attendees are encouraged to participate in open-floor Q&A.
For more information on the 3rd Annual Pharmaceutical Strategic Pricing and Market Access Conference, please visit www.q1productions.com/rxpricing or email firstname.lastname@example.org. You can also follow the conference on Twitter @Q1Productions, #Q1RxPricing.